Get the app
US › Healthcare

Fresenius Medical Care Corporation (FMS)

US · Healthcare · Medical Care Facilities

$22.17+0.18%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$4.86B
Revenue YoY
+1.4%
Net profit
$218.4M
Profit YoY
-3.1%
EPS
$0.66
EPS estimate
$0.50
Net margin
4.5%

EPS came in at 0.66 against a street estimate of 0.50 — a beat of 32.0%.

Key statistics

Market cap
$11.46B
P/E
10.9
Forward P/E
8.6
P/B
0.83
Book value
$26.43
EPS (TTM)
$1.98
Dividend yield
4.13%
52-week high
$26.42
52-week low
$19.24
50-day MA
$22.75
200-day MA
$22.93
Beta
0.81

Analyst view

Analysts rate Fresenius Medical Care Corporation a hold (1 buy, 3 hold, 3 sell out of 7) with an average price target of $23.88.

Shareholding

Institutions
9.86%

Largest institutional holders

FundStake
Pzena Investment Management, LLC2.82%
Morgan Stanley - Brokerage Accounts0.82%
Dodge & Cox0.72%
Fiduciary Management, Inc. of Milwaukee0.55%
Brandes Investment Partners & Co0.36%
Millennium Management LLC0.30%
Todd Asset Management0.25%
The Goldman Sachs Group Inc0.17%

Recent filings & reports

DocumentDate
Current report (6-K) · Q4 2026
OTHER NOTABLE POINTS • Fresenius Medical Care AG filed a Form 6-K with the U.S. Securities and Exchange Commission for October 2026. • The filing in
2026-10-07
Current report (6-K) · Q3 2026
OTHER NOTABLE POINTS • Fresenius Medical Care AG filed a Form 6-K with the U.S. Securities and Exchange Commission for September 2026. • The filing
2026-09-25
Current report (6-K) · Q3 2026
HEADLINE NUMBERS • A multinational real-world study associated hemodiafiltration (HDF) with a 28% lower relative risk of all-cause mortality versus c
2026-08-27
Current report (6-K) · Q2 2026
HEADLINE NUMBERS • The document is Fresenius Medical Care AG’s unaudited interim report for the three and six months ended June 30, 2026, compared wi
2026-08-04
Current report (6-K) · Q3 2026
HEADLINE NUMBERS • The document is a Form 6-K filed by Fresenius Medical Care AG on August 3, 2026. • It covers the month of August 2026 and include
2026-08-03
Annual report FY2025 (20-F)
HEADLINE NUMBERS • Fiscal year covered: December 31, 2025; reporting under International Financial Reporting Standards issued by the International Ac
2026-02-24
Annual report FY2024 (20-F)2025-02-25
Annual report FY2023 (20-F)2024-02-20

Readable in the app.

Corporate actions

ActionDetailDate
Dividend$0.87 / share
ex-date May 22, 2026 · pay Jun 8, 2026
2026-05-22

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Fresenius Medical Care Corporation — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Data updated 2026-10-19.